drugset / Trial / NCT02915978

Fentanyl Sublingual Spray for the Treatment of Moderate to Severe Post-Operative Pain

NCT02915978

Phase 2 Completed 45 enrolled INSYS Therapeutics Inc
RandomizedParallel-groupDouble-blindTreatment

Summary

The primary objective of this trial is to evaluate analgesic efficacy of Fentanyl Sublingual Spray compared with placebo in participants with postoperative pain after a bunionectomy.

Timeline

Start
2016-12
Primary completion
2017-02-10
Completion
2017-02-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Fentanyl Other / unclassified Other

Indications

No indication recorded.